Wainua

Pharmaceutical product

Business Health Europe

AstraZeneca Shares Plunge on Drug Trial Failure

AstraZeneca’s stock crashed after its heart drug Wainua failed a key clinical trial.

AstraZeneca stock plunges after late-stage heart drug trial misses its target Quartz — Jul 09, 11:20 AM
AstraZeneca sees stock market value slump by more than £20bn after drug setback Yorkshire Post — Jul 09, 10:47 AM
AstraZeneca sees stock market value slump by more than £20bn after drug setback The Argus — Jul 09, 10:39 AM